Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2023-02-10 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the completion of a USFDA inspection and issuance of Form 483 with observations. The document is brief (1314 characters), contains no financial data or detailed report, and serves as a regulatory announcement of an event affecting the company. It does not contain an audit report, annual report, or financial statements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-02-10 English
Copy of Newspaper Publication
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper advertisement about a Postal Ballot Notice for the reappointment of an Executive Director. It includes details about the advertisement publication and references to shareholder approval via e-voting. The content is primarily an announcement of a shareholder voting process and related advertisement, not the actual voting results or detailed meeting materials. The document is about informing the exchanges of the advertisement publication, not the AGM materials or voting results themselves. Therefore, it fits best under Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is about the Postal Ballot Notice advertisement seeking approval (proxy solicitation), it aligns more with Proxy Solicitation & Information Statement (PSI). The document length is 15,000 characters, indicating it is not a brief announcement but contains detailed solicitation information. Hence, the classification is PSI with high confidence.
2023-02-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of analyst and institutional investor meetings held on February 6, 2023. It references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is an announcement of meetings and does not contain financial data, earnings, or detailed reports. It is not a report itself but an update on investor relations activities. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2023-02-06 English
Shareholders meeting
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Postal Ballot Notice issued by Laurus Labs Limited, dated February 6, 2023. It is addressed to stock exchanges and shareholders, informing them about a special resolution to be passed through remote e-voting regarding the re-appointment of an Executive Director. The document includes details about the voting period, instructions for e-voting, and the resolution text. It is a notice for shareholders to vote on a corporate governance matter, not a report of voting results or a management report. It does not contain financial statements or earnings data. The document is a formal notice for a shareholder vote conducted via postal ballot, which fits the category of Proxy Solicitation & Information Statement (PSI) as it solicits shareholder votes and provides information about the resolution and voting process.
2023-02-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of Laurus Labs Limited's Q3 FY '23 Earnings Conference Call held on January 30, 2023. It includes detailed discussions of quarterly and nine-month financial results, business updates, product pipeline, R&D progress, and Q&A with investors. The presence of management commentary, financial figures, and Q&A format clearly identifies this as a call transcript of earnings results rather than a formal earnings release or annual/interim report. The document length (15,000 characters) and content confirm it is a full transcript, not a brief announcement or presentation. Therefore, the appropriate classification is Call Transcript (CT).
2023-02-04 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the audio recording of a Q3 FY23 results conference call. It references the conference call and provides a web link to the audio recording, but does not contain the transcript or detailed financial data itself. The document length is only 1200 characters, which is quite short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, such a document that announces or provides access to a report or recording without including substantive content should be classified as a Regulatory Filing (RNS).
2023-01-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.